James Armitage

James Armitage

Director/Board Member at TESARO INC

Net worth: 52 231 $ as of 2026-05-30

79 year
Health Technology
Consumer Services
Health Services

Profile

James O.
Armitage
is currently Director at Tesaro, Inc. since 2013, Independent Director at Cardiff Oncology, Inc. since 2020, and Professor-Internal Medicine at the University of Nebraska Medical Center since 2003.
Former positions include Director at MGI PHARMA, Inc. from 2006 to 2008, President & Director at the American Society of Clinical Oncology, Inc., and President at the American Society for Blood & Marrow Transplantation.
Education includes undergraduate studies at the University of Nebraska and a doctorate from the University of Nebraska Medical Center.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-04-19 27,490 ( 0.04% ) 52 231 $ 2026-05-30

James Armitage active positions

CompaniesPositionStart
TESARO INC Director/Board Member 2013-05-08
CARDIFF ONCOLOGY, INC. Director/Board Member 2020-04-21
Corporate Officer/Principal 1981-12-31

Former positions of James Armitage

CompaniesPositionEnd
Director/Board Member 2008-01-28
President -
President -
See the detail of James Armitage's experience

Training of James Armitage

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

58

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Services

  1. Stock Market
  2. Insiders
  3. James Armitage
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!